Standout Papers

T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mu... 2017 2026 2020 2023 630
  1. T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028 (2018)
    Patrick A. Ott, Yung‐Jue Bang et al. Journal of Clinical Oncology
  2. Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial (2017)
    Jean‐Sébastien Frenel, Christophe Le Tourneau et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 6 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Palliative Care for Patients With Cancer: ASCO Guideline Update
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout

Works of Bert H. O’Neil being referenced

T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
2018 Standout
Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers
2017

Author Peers

Author Last Decade Papers Cites
Bert H. O’Neil 5574 1921 2434 252 8.8k
Sandro Pignata 4221 1483 2395 407 10.2k
Brigette Ma 4705 2288 2640 243 9.9k
Howard S. Höchster 7935 3251 2371 335 11.7k
Edwin P. Hui 3857 1714 2136 170 8.7k
Seppo Pyrhönen 4168 2260 2426 225 8.3k
Dongyun Yang 4256 1620 2599 309 7.7k
Hans Prenen 3897 2558 2584 202 8.3k
Rocio García‐Carbonero 6486 2051 2357 304 9.4k
David Khayat 5160 2557 2334 103 8.2k
Paul Ruff 6251 2538 1393 153 8.6k

All Works

Loading papers...

Rankless by CCL
2026